Merger Arbitrage Performance Review – October 11, 2020
This is the weekly Merger Arbitrage Performance Review - October 11, 2020. This report focusses on VRTU, TIF & IMMU arbitrage spreads during the period 5th…
Immunomedics (NASDAQ: IMMU) Acquisition
Immunomedics (IMMU) Acquisition
Gilead Sciences (GILD) and Immunomedics (IMMU) $21bn acquisition information including expected completion date, offer price and contact details are displayed in the acquisition details table…
